+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ovarian Cancer Drugs Market Research Reports

From
From
Ovarian Cancer Drugs Global Market Report 2020 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2020

  • Report
  • December 2019
  • 200 Pages
From
From
The 2021-2026 World Outlook for Ovarian Cancer Drugs - Product Thumbnail Image

The 2021-2026 World Outlook for Ovarian Cancer Drugs

  • Report
  • November 2019
  • 299 Pages
Global Ovarian Cancer Drugs Market 2019-2023 - Product Thumbnail Image

Global Ovarian Cancer Drugs Market 2019-2023

  • Report
  • February 2019
  • 117 Pages
From
From
From
CAS 645-05-6 Altretamine Chemical World Report - Product Thumbnail Image

CAS 645-05-6 Altretamine Chemical World Report

  • Report
  • August 2020
  • 2103 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • August 2020
  • 2111 Pages
CAS 95058-81-4 Gemcitabine Chemical World Report - Product Thumbnail Image

CAS 95058-81-4 Gemcitabine Chemical World Report

  • Report
  • August 2020
  • 2134 Pages
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • August 2020
  • 2011 Pages
Loading Indicator

Far less common than breast cancer, but with a higher mortality rate, sufferers of ovarian cancer are experiencing significant unmet needs. There are therefore considerable market opportunities for drug designers and manufacturers in this life-saving sector of the pharmaceutical industry. In this section a host of cutting edge reports provide valuable insight into key markets such as China and the US, the latest drug development activities and the market trends (including sales, pricing and forecasts) for specific drugs like Doxil, Caelyx, Yondelis and Paclitaxel. You can also purchase reports that feature the latest strategies of major and niche industry players such as Alza Corporation, Amgen, Bristol-Myers Squibb, Cell Therapeutics, Genentech, GlaxoSmithKline, Immunogen, Ivax, OSI Pharmaceuticals and Raven Biotechnologies.
Show Less
Read more

adroll